Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in ischemic disease.

H H Marti1, W Risau

  • 1Max Planck Institute for Physiological and Clinical Research, Department of Molecular Cell Biology, Bad Nauheim, Germany. hugo.marti@kerckhoff.mpg.de

Thrombosis and Haemostasis
|March 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation.

Placenta·2003
Same author

Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1.

Microvascular research·2001
Same author

Erythropoietin expression in primary rat Sertoli and peritubular myoid cells.

Blood·2001
Same author

Nucleotide sequence of the mouse VEGF 3'UTR and quantitative analysis of sites of polyadenylation.

Biochimica et biophysica acta·2001
Same author

A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.

Blood·2001
Same author

Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.

International journal of cancer·2001

Therapeutic angiogenesis using growth factors shows promise for treating ischemic diseases by promoting blood vessel formation. Further research is needed to optimize delivery methods and minimize side effects like edema.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Developmental Biology

Background:

  • Angiogenic growth factors and their receptors are crucial for blood vessel formation.
  • Key pathways include Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor (VEGF/VEGFR) and Angiopoietin/Tie2.
  • Defects in these pathways lead to embryonic lethality.

Purpose of the Study:

  • To explore the role of angiogenic growth factors in vascular development and disease.
  • To evaluate the potential of therapeutic angiogenesis for treating ischemic conditions.
  • To identify optimal delivery methods and assess potential side effects.

Main Methods:

  • Review of existing literature on angiogenic pathways and therapeutic angiogenesis.

Related Experiment Videos

  • Analysis of data from animal models and human clinical trials.
  • Discussion of various delivery methods including recombinant proteins, naked DNA, and viral vectors.

    • Main Results:

    • VEGF/VEGFR and Angiopoietin/Tie2 systems are vital for embryonic vascularization.
    • Therapeutic angiogenesis has shown efficacy in animal models of ischemia.
    • Clinical trials suggest potential benefits for cardiovascular diseases.

    Conclusions:

    • Therapeutic angiogenesis holds promise for treating ischemic diseases like myocardial infarction and arterial occlusive disease.
    • Further research is required to optimize delivery strategies and mitigate side effects such as edema and vascular permeability.
    • Exogenous administration of angiogenic factors, particularly via naked DNA or protein injection, is an encouraging therapeutic approach.